Precision medicine in acute lymphoblastic leukemia.
Pui CH.
Front Med. 2020 Dec;14(6):689-700. doi: 10.1007/s11684-020-0759-8. Epub 2020 Oct 19.
Targeted Drug Delivery: Trends and Perspectives.
Ashique S, Sandhu NK, Chawla V, Chawla PA.
Curr Drug Deliv. 2021;18(10):1435-1455. doi: 10.2174/1567201818666210609161301.
OXPHOS-targeting drugs in oncology: new perspectives.
Kalyanaraman B, Cheng G, Hardy M, You M.
Expert Opin Ther Targets. 2023 Jul-Dec;27(10):939-952. doi: 10.1080/14728222.2023.2261631. Epub 2023 Oct 30.
Targeting pan-essential genes in cancer: Challenges and opportunities.
Chang L, Ruiz P, Ito T, Sellers WR.
Cancer Cell. 2021 Apr 12;39(4):466-479. doi: 10.1016/j.ccell.2020.12.008. Epub 2021 Jan 14.
Hybrid proton-photon inverse optimization with uniformity-regularized proton and photon target dose.
Gao H.
Phys Med Biol. 2019 May 8;64(10):105003. doi: 10.1088/1361-6560/ab18c7.
Heterogeneous Off-Target Effects of Ultra-Low Dose Dimethyl Sulfoxide (DMSO) on Targetable Signaling Events in Lung Cancer In Vitro Models.
Baldelli E, Subramanian M, Alsubaie AM, Oldaker G, Emelianenko M, El Gazzah E, Baglivo S, Hodge KA, Bianconi F, Ludovini V, Crino' L, Petricoin EF, Pierobon M.
Int J Mol Sci. 2021 Mar 10;22(6):2819. doi: 10.3390/ijms22062819.
Should we target TNF receptors in the intestinal epithelium with glucocorticoids during systemic inflammation?
Van Looveren K, Libert C.
Expert Opin Ther Targets. 2018 Dec;22(12):1029-1037. doi: 10.1080/14728222.2018.1539078. Epub 2018 Oct 23.
Target-Based Radiosensitization Strategies: Concepts and Companion Animal Model Outlook.
Berry MR, Fan TM.
Front Oncol. 2021 Oct 20;11:768692. doi: 10.3389/fonc.2021.768692. eCollection 2021.
Drug targeting.
Torchilin VP.
Eur J Pharm Sci. 2000 Oct;11 Suppl 2:S81-91. doi: 10.1016/s0928-0987(00)00166-4.
Drug Delivery Based on Nanotechnology for Target Bone Disease.
Yang X, Chen S, Liu X, Yu M, Liu X.
Curr Drug Deliv. 2019;16(9):782-792. doi: 10.2174/1567201816666190917123948.
